SCHEMBL4929176

SCHEMBL4929176

COc1cc(CNC(=O)c2ccc(N)c(O)c2)cc(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 3/20 0.54
NAMPT P43490 2/20 0.52
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TP53 P04637 1/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.51
HPGD P15428 2/20 0.49
KDM4E B2RXH2 1/20 0.49
USP2 O75604 1/20 0.49
ALDH1A1 P00352 1/20 0.49
WDR5 P61964 3/20 0.47
MEN1 O00255 1/20 0.47
EPHX2 P34913 1/20 0.47
KMT2A Q03164 1/20 0.47
NR1H4 Q96RI1 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAOB P27338 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928213 0.79 PLAU (0.59) RAB9ALMNAHPGDALDH1A1NR1H4
SCHEMBL3018285 0.78 HDAC1 (0.63) MMP13NAMPTNPC1RAB9ALMNA
SCHEMBL13450623 0.78 EPHX2 (0.53) MMP13NAMPTNPC1RAB9ALMNA
SCHEMBL1535771 0.77 MMP13 (0.67) MMP13NAMPTNPC1RAB9ALMNA
SCHEMBL4925881 0.77 L3MBTL1 (0.55) LMNASMN1; SMN2TP53MAPTMEN1
SCHEMBL4925058 0.76 ALOX5 (0.52) MMP13NAMPTNPC1RAB9ALMNA
SCHEMBL13175754 0.76 PDE4A (0.63) NPC1RAB9ALMNASMN1; SMN2ALDH1A1
SCHEMBL6296069 0.76 NPC1 (0.60) MMP13NPC1RAB9ASMN1; SMN2TP53
SCHEMBL4927561 0.76 NR1H4 (0.61) NPC1RAB9ATP53MAPTHPGD
SCHEMBL3112864 0.75 ALOX15 (0.51) RAB9ALMNASMN1; SMN2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 MMP13 781/4885NAMPT 3190/4885NPC1 1166/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 MMP13 898/4885NAMPT 3287/4885NPC1 1034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.